中国药品安全社会共治的制度分析与安排
发布时间：2018-11-04 13:25
【摘要】：中国既有研究中缺乏针对药品安全社会共治制度安排的研究,理论上对于药品安全与食品安全社会共治的制度安排有何区别存在研究盲点。本文从中国药品安全社会共治"预防-免疫-治疗"三级协同制度安排构建框架出发,分别对药品安全社会共治的"预防"体系的制度构建、"免疫"体系的制度构建及"治疗"体系的制度构建进行了分析和讨论。研究表明,无论在"预防"体系还是"免疫"体系下,或者在"治疗"体系下,药品安全社会共治制度安排的行动主体、行动情境、交互模式和潜在结果,都呈现出与食品安全社会共治不同的制度特征。在此基础上,本文对构建药品安全社会共治制度安排提出政策建议。研究结论可为中国药品安全社会共治从侧重事后"治疗"体系,向事后与事前"预防"和"免疫"体系平衡监管的方向转型实践,提供理论基础和策略依据。
[Abstract]:There is a lack of research on the system arrangement of drug safety social co-governance in China. In theory, there is a blind spot on the differences between drug safety and food safety social co-governance. Starting from the framework of the three-level cooperative system arrangement of "preventive immune-therapy" in Chinese drug safety society, this paper sets out the system construction of "prevention" system of drug safety society co-treatment respectively. The system construction of immune system and treatment system are analyzed and discussed. Studies have shown that, whether in the "prevention" system, the "immune" system, or the "therapeutic" system, the main body of action, the action context, the interaction model and the potential results of the drug safety social co-treatment system, Both show different institutional characteristics from food safety society. On this basis, this paper puts forward some policy suggestions on the construction of drug safety social co-governance system. The conclusion of the study can provide theoretical basis and strategic basis for the transformation from "treatment" system to "prevention" and "immune" system balance supervision in Chinese drug safety society.
【作者单位】： 中山大学管理学院;
【基金】：国家社会科学基金重大招标项目“食品药品安全社会共治的制度安排:需求、设计、实现与对策研究”(14ZDA074)的阶段性成果
【分类号】：R95
，
本文编号：2309945
[Abstract]:There is a lack of research on the system arrangement of drug safety social co-governance in China. In theory, there is a blind spot on the differences between drug safety and food safety social co-governance. Starting from the framework of the three-level cooperative system arrangement of "preventive immune-therapy" in Chinese drug safety society, this paper sets out the system construction of "prevention" system of drug safety society co-treatment respectively. The system construction of immune system and treatment system are analyzed and discussed. Studies have shown that, whether in the "prevention" system, the "immune" system, or the "therapeutic" system, the main body of action, the action context, the interaction model and the potential results of the drug safety social co-treatment system, Both show different institutional characteristics from food safety society. On this basis, this paper puts forward some policy suggestions on the construction of drug safety social co-governance system. The conclusion of the study can provide theoretical basis and strategic basis for the transformation from "treatment" system to "prevention" and "immune" system balance supervision in Chinese drug safety society.
【作者单位】： 中山大学管理学院;
【基金】：国家社会科学基金重大招标项目“食品药品安全社会共治的制度安排:需求、设计、实现与对策研究”(14ZDA074)的阶段性成果
【分类号】：R95
，
本文编号：2309945
本文链接：https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/2309945.html
最近更新
教材专著
